Catherine Corrigan sold $529k of EXPO
President & CEO at EXPONENT INC. 7,821 shares at an average of $67.59, traded Mar 16, 2026, filed Apr 16, 2026.
Score components
- +25RoleCEO
- +18Trade size$529k at market
- 0Share of holdings soldSold 7.5% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -21.0%, 3m -5.0%, 6m -.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000851520-26-000057, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | MOption exercise Common Stock10b5-1 | +3,226 | $25.41 | $82k | 104,195 | Apr 16, 2026 |
| Mar 16, 2026 | SOpen-market sale Common Stock10b5-1 | -2,214 | $67.49 | $149k | 101,981 | Apr 16, 2026 |
| Mar 16, 2026 | MOption exercise Common Stock10b5-1 | +2,380 | $29.05 | $69k | 104,361 | Apr 16, 2026 |
| Mar 16, 2026 | SOpen-market sale Common Stock10b5-1 | -1,698 | $67.49 | $115k | 102,663 | Apr 16, 2026 |
| Apr 15, 2026 | MOption exercise Common Stock10b5-1 | +3,225 | $25.41 | $82k | 105,888 | Apr 16, 2026 |
| Apr 15, 2026 | SOpen-market sale Common Stock10b5-1 | -2,212 | $67.70 | $150k | 103,676 | Apr 16, 2026 |
| Apr 15, 2026 | MOption exercise Common Stock10b5-1 | +2,380 | $29.05 | $69k | 106,056 | Apr 16, 2026 |
| Apr 15, 2026 | SOpen-market sale Common Stock10b5-1 | -1,697 | $67.70 | $115k | 104,359 | Apr 16, 2026 |
| Mar 16, 2026 | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -3,226 | - | - | 9,676 | Apr 16, 2026 |
| Apr 15, 2026 | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -3,225 | - | - | 6,451 | Apr 16, 2026 |
| Mar 16, 2026 | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -2,380 | - | - | 11,898 | Apr 16, 2026 |
| Apr 15, 2026 | MOption exercise Non-Qualified Stock Option (right to buy)derivative10b5-1 | -2,380 | - | - | 9,518 | Apr 16, 2026 |
Related signals
Other insiders at EXPONENT INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | EXPObuy EXPONENT INC | Shukri Jeries Souri Group Vice President | $13k 184 shares | +0% | |
| 0Weak | EXPONENT INC | Catherine Corrigan Chief Executive Officer | $113k 1,707 shares | -1% | |
| 0Weak | EXPONENT INC | Catherine Corrigan Chief Executive Officer | $109k 1,737 shares | -1% | |
| 3Weak | EXPONENT INC | Catherine Corrigan President & CEO | $235k 4,119 shares | -4% | |
| 60Notable | EXPONENT INC | Bradley A James Group Vice President | $115k 2,000 shares | -64% | |
| 50Moderate | EXPONENT INC | Richard Reiss Group Vice President | $98k 1,672 shares | -42% | |
| 18Weak | EXPONENT INC | Catherine Corrigan President & CEO | $227k 4,194 shares | -4% | |
| 60Notable | EXPONENT INC | Joseph Sala Group Vice President | $117k 2,066 shares | -100% | |
| 61Notable | EXPONENT INC | Joseph Rakow Group Vice President | $161k 2,945 shares | -100% | |
| 11Weak | EXPONENT INC | Catherine Corrigan President & CEO | $263k 3,920 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.